Cargando…
Evaluation of variability in target volume delineation for newly diagnosed glioblastoma: a multi-institutional study from the Korean Radiation Oncology Group
BACKGROUND: This study aimed for a collaborative evaluation of variability in the target volumes for glioblastoma, determined and contoured by different radiotherapy (RT) facilities in Korea. METHODS: Fifteen panels of radiation oncologists from independent institutions contoured the gross target vo...
Autores principales: | Wee, Chan Woo, Sung, Wonmo, Kang, Hyun-Cheol, Cho, Kwan Ho, Han, Tae Jin, Jeong, Bae-Kwon, Jeong, Jae-Uk, Kim, Haeyoung, Kim, In Ah, Kim, Jin Hee, Kim, Sung Hwan, Kim, Suzy, Lee, Dong Soo, Lee, Me Yeon, Lim, Do Hoon, Park, Hye Li, Suh, Chang-Ok, Yoon, Sang Min, Kim, Il Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489390/ https://www.ncbi.nlm.nih.gov/pubmed/26134973 http://dx.doi.org/10.1186/s13014-015-0439-z |
Ejemplares similares
-
Feasibility of hippocampus-sparing VMAT for newly diagnosed glioblastoma treated by chemoradiation: pattern of failure analysis
por: Wee, Chan Woo, et al.
Publicado: (2020) -
CXCR4-STAT3 Axis Plays a Role in Tumor Cell Infiltration in an Orthotopic Mouse Glioblastoma Model
por: Han, Ji-hun, et al.
Publicado: (2020) -
Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis
por: Roh, Tae Hoon, et al.
Publicado: (2017) -
The Korean Society for Neuro-Oncology (KSNO) Guideline for Glioblastomas: Version 2018.01
por: Kim, Young Zoon, et al.
Publicado: (2019) -
Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea
por: Kim, Byung Sup, et al.
Publicado: (2017)